Advanced bone health screening and clinical reversal for London’s professional workforce.
Designed for organisations where senior capability and leadership continuity are strategic assets.
Osteoporosis costs UK employers £129 million in lost productivity every year. The fractures driving those losses begin silently — no pain, no warning — in professionals aged 40 to 60. The seniority of those most affected maps precisely onto your most valuable fee earners, partners, and executives.
A single senior associate or partner hip fracture costs a firm £200,000–£500,000 in lost billing, recruitment, and knowledge transfer. One corporate screening programme costs a fraction of that — and identifies the individuals at risk before an event occurs.
From £3,500
Groups of 10–60 employees. FRAX-based fracture risk assessment, clinical consultation, and personalised bone health report per participant. Fast-track DXA referral for those identified as high-risk.
£5,750 fixed fee
For board members, senior partners, and key persons. A full health risk intelligence assessment. Individual data ownership. Participation certificate for the organisation only.
From £18,000/year
Annual agreements with screening days, BoneRevive® memberships, board-level reporting, and co-created thought leadership. For firms embedding bone health as a core pillar of their wellbeing strategy.
Unlike general corporate health MOTs, the London Osteoporosis Clinic delivers specialist bone density assessment interpreted by a Consultant Rheumatologist with over 30 years of experience in osteoporosis and metabolic bone disease — and a clinical pathway that actively reverses bone loss, not just detects it.
All clinical assessments and findings remain strictly confidential to the individual participant. No personal medical data is shared with employers.
Organisations receive confirmation of programme participation only. Clinical duty of care rests entirely with the patient and the treating clinician.
This means your employees receive specialist medical care with complete privacy — while you fulfil your duty of care and provide a genuinely valuable executive health benefit.
Protecting the health and professional independence of your senior people.
Bone health screening is the clinical extension of any menopause support programme. Menopause causes up to 20% bone loss — LOC measures and reverses it.
Fracture prevention avoids prolonged rehabilitation, succession disruption, and knowledge loss.
A meaningful, differentiated benefit that senior professionals value — and that your firm’s wellbeing programme does not yet include.
DXA-tracked, measurable outcomes. Aggregate anonymised reporting for your wellbeing and board-level ESG reporting.
The London Osteoporosis Clinic is led by Dr Taher Mahmud FRCP, Consultant Rheumatologist with over 30 years of specialist experience in osteoporosis and metabolic bone disease. Dr Mahmud holds two US patents in osteoporosis prevention and reversal and has treated over 10,000 patients, with 125+ referring clinicians across the UK.
The clinic operates from HCA The Shard, London, and is affiliated with the Global Osteoporosis Foundation. Consultations are also available in Tunbridge Wells.
To discuss a corporate screening programme, KPHRI™ Executive Review, or long-term bone health partnership, contact the clinic directly.
GET LATEST UPDATES
© 2026 London Osteoporosis Clinic.
